Similarly, IR of radiotherapy activates innate immune pathways, leading to the upregulation of PD-L1 in hepatocellular carcinoma (HCC), inhibition of cytotoxic T lymphocytes activity and immune infiltration, and protection of tumor cells from cellular immune-mediated killing (Du et al., 2022). This evidence concerns the gene CD274 and hepatocellular carcinoma.